Crossmark

Cytoprotective Drug-Tissue Plasminogen Activator Protease Interaction Assays: Screening of Two Novel Cytoprotective Chromones

Published Online: 2017-04-12

Published Print: 2017-10

Authors

Lapchak, Paul A.

Lara, Jacqueline M.

Boitano, Paul D.
Funding

Funding for this research was provided by:

National Institute of Neurological Disorders and Stroke (NS060685)
License Information

Text and Data Mining valid from 2017-04-12

Version of Record valid from 2017-04-12
More Information

Article History

Received: 20 January 2017

Revised: 21 February 2017

Accepted: 27 March 2017

First Online: 12 April 2017

Compliance with Ethical Standards

:

: PAL is Associate Editor for Translational Stroke Research and Editor-in-Chief for Journal of Neurology & Neurophysiology. PAL has no other potential conflict of interest to report. JML and PDB have no conflict of interest to report.

: The scientific content of this work was not directly supported by any grant or funding agency. PAL was supported in part by a U01 Translational Research grant NS060685 for drug candidate selection.

: This article does not contain any studies with human participants or animals performed by any of the authors.

Document is current